Her main research concerns Prostate cancer, Cancer research, Cancer, Prostate and Chromoplexy. Francesca Demichelis has included themes like Fusion gene, Oncology and Cancer biomarkers in her Prostate cancer study. The various areas that Francesca Demichelis examines in her Cancer research study include Cell, ETS transcription factor family, Immunology and Pathology.
Francesca Demichelis has researched Cancer in several fields, including Exome sequencing and Functional genomics. Her study in Prostate is interdisciplinary in nature, drawing from both Immunohistochemistry, Gene knockdown, DNA methylation, Bioinformatics and Adenocarcinoma. Her Chromoplexy study incorporates themes from Carcinogenesis and PTEN.
Francesca Demichelis mainly focuses on Prostate cancer, Cancer research, Cancer, Internal medicine and Oncology. The concepts of her Prostate cancer study are interwoven with issues in Prostate and Pathology. The Prostate study combines topics in areas such as Gene expression profiling and Adenocarcinoma.
The study incorporates disciplines such as Phenotype, Lineage, Gene, Somatic evolution in cancer and DNA methylation in addition to Cancer research. Her Cancer research includes themes of Exome sequencing, Bioinformatics, Fusion gene, Epigenetics and PTEN. Her Oncology research is multidisciplinary, relying on both Prospective cohort study, Proportional hazards model, PCA3 and Cohort.
Her primary areas of investigation include Prostate cancer, Cancer research, Computational biology, Cancer and Genome. Her studies in Prostate cancer integrate themes in fields like Transcriptome, Oncology and PTEN. Her Cancer research study integrates concerns from other disciplines, such as Phenotype, Prostate, Epigenetics and DNA methylation.
Her work on Cyclin-dependent kinase, Cell cycle and E2F as part of general Cancer research is often related to Digital polymerase chain reaction, thus linking different fields of science. Her biological study spans a wide range of topics, including Genotype, Ploidy, Mutation and DNA sequencing. Her Androgen receptor research incorporates elements of Chromoplexy and MED12.
Francesca Demichelis focuses on Prostate cancer, Cancer research, DNA methylation, Epigenomics and Epigenetics. Her studies deal with areas such as Biopsy, Prostate and Cancer biomarkers as well as Prostate cancer. Cancer research is often connected to Genome-wide association study in her work.
Her work carried out in the field of DNA methylation brings together such families of science as Methylation, Mutation rate and microRNA. Her research integrates issues of Exome sequencing, Exome, Mutation and Carcinogenesis in her study of Epigenetics. Francesca Demichelis combines subjects such as Carcinoma, Oncology, Clinical trial and Genomics with her study of Androgen receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei.
(2010)
Integrative clinical genomics of advanced prostate cancer
Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz.
Cell (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally.
Cell (2015)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri;Sylvan C. Baca;Sylvan C. Baca;Michael S. Lawrence;Francesca Demichelis;Francesca Demichelis.
Nature Genetics (2012)
The genomic complexity of primary human prostate cancer
Michael F. Berger;Michael F. Berger;Michael S. Lawrence;Francesca Demichelis;Yotam Drier.
Nature (2011)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C Baca;Davide Prandi;Michael S Lawrence;Juan Miguel Mosquera.
Cell (2013)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim;Gad Getz;Leia Nghiemphu;Jordi Barretina.
Proceedings of the National Academy of Sciences of the United States of America (2007)
The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
Leming Shi;Gregory Campbell;Wendell D. Jones;Fabien Campagne.
Nature Biotechnology (2010)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran;Himisha Beltran;Davide Prandi;Juan Miguel Mosquera;Juan Miguel Mosquera;Matteo Benelli.
Nature Medicine (2016)
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
F. Demichelis;K. Fall;S. Perner;S. Perner;O. Andrén.
Oncogene (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Bern
Cornell University
Harvard University
Cornell University
Harvard University
University of Michigan–Ann Arbor
Cornell University
Harvard University
Harvard University
Broad Institute
Southwest Jiaotong University
Technical University of Berlin
University of Wisconsin–Madison
University of Hyogo
University of Chicago
Auburn University
Centers for Disease Control and Prevention
University of Göttingen
Boston University
The Pirbright Institute
Pacific Northwest National Laboratory
University of Pretoria
University of Liverpool
Cedars-Sinai Medical Center
Michigan State University
Columbia University